Is adjuvant therapy for stage II colon cancer worthwhile, and for whom? Commentary Journal Article

  

Authors:	Segal, N. H.; Saltz, L. B.
Article Title:	Is adjuvant therapy for stage II colon cancer worthwhile, and for whom? Commentary
Keywords:	cancer survival; clinical trial; cancer recurrence; fluorouracil; placebo; cancer adjuvant therapy; cancer staging; drug megadose; colorectal cancer; low drug dose; cancer mortality; confidence interval; drug cost; drug fatality; statistical significance; folinic acid; colon resection; short survey; repeated drug dose; rectum resection; clinical observation; levamisole
Journal Title:	Nature Clinical Practice Gastroenterology & Hepatology
Volume:	5
Issue:	8
ISSN:	1743-4378
Publisher:	Nature Publishing Group
Date Published:	2008-01-01
Start Page:	422
End Page:	423
Language:	English
DOI:	10.1038/ncpgasthep1181
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-49249129574&partnerID=40&md5=26967f08b3065840e1c60cce4b1179e4
Notes:	--- - "Cited By (since 1996): 2" - "Export Date: 17 November 2011" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15325